ERNA vs TPR · P/E 0.0, rev $582.0K vs P/E 46, rev $8.00B
Eterna Therapeutics Inc (ERNA) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the ERNA and TPR stock pages for the full models.
Not investment advice.